Variation in aggregation propensities among ALS-associated variants of SOD1

Correlation to human disease

Mercedes Prudencio, P. John Hart, David R. Borchelt, Peter M. Andersen

Research output: Contribution to journalArticle

139 Citations (Scopus)

Abstract

To date, 146 different mutations in superoxide dismutase 1 (SOD1) have been identified in patients with familial amyotrophic lateral sclerosis (ALS). The mean age of disease onset in patients inheriting mutations in SOD1 is 45-47 years of age. However, although the length of disease duration is highly variable, there are examples of consistent disease durations associated with specific mutations (e. g. A4V, less than 2 years). In the present study, we have used a large set of data from SOD1-associated ALS pedigrees to identify correlations between disease features and biochemical/biophysical properties of more than 30 different variants of mutant SOD1. Using a reliable cell culture assay, we show that all ALS-associated mutations in SOD1 increase the inherent aggregation propensity of the protein. However, the relative propensity to do so varied considerably among mutants. We were not able to explain the variation in aggregation rates by differences in known protein properties such as enzyme activity, protein thermostability, mutation position or degree of change in protein charge. Similarly, we were not able to explain variability in the duration of disease in SOD1-associated ALS pedigrees by these properties. However, we find that the majority of pedigrees in which patients exhibit reproducibly short disease durations are associated with mutations that show a high inherent propensity to induce aggregation of SOD1.

Original languageEnglish (US)
Pages (from-to)3217-3226
Number of pages10
JournalHuman Molecular Genetics
Volume18
Issue number17
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Amyotrophic Lateral Sclerosis
Mutation
Pedigree
Proteins
Superoxide Dismutase-1
Age of Onset
Cell Culture Techniques
Enzymes

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Variation in aggregation propensities among ALS-associated variants of SOD1 : Correlation to human disease. / Prudencio, Mercedes; Hart, P. John; Borchelt, David R.; Andersen, Peter M.

In: Human Molecular Genetics, Vol. 18, No. 17, 2009, p. 3217-3226.

Research output: Contribution to journalArticle

Prudencio, Mercedes ; Hart, P. John ; Borchelt, David R. ; Andersen, Peter M. / Variation in aggregation propensities among ALS-associated variants of SOD1 : Correlation to human disease. In: Human Molecular Genetics. 2009 ; Vol. 18, No. 17. pp. 3217-3226.
@article{db6a066eb24c4ee4960398c59b0d89a1,
title = "Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease",
abstract = "To date, 146 different mutations in superoxide dismutase 1 (SOD1) have been identified in patients with familial amyotrophic lateral sclerosis (ALS). The mean age of disease onset in patients inheriting mutations in SOD1 is 45-47 years of age. However, although the length of disease duration is highly variable, there are examples of consistent disease durations associated with specific mutations (e. g. A4V, less than 2 years). In the present study, we have used a large set of data from SOD1-associated ALS pedigrees to identify correlations between disease features and biochemical/biophysical properties of more than 30 different variants of mutant SOD1. Using a reliable cell culture assay, we show that all ALS-associated mutations in SOD1 increase the inherent aggregation propensity of the protein. However, the relative propensity to do so varied considerably among mutants. We were not able to explain the variation in aggregation rates by differences in known protein properties such as enzyme activity, protein thermostability, mutation position or degree of change in protein charge. Similarly, we were not able to explain variability in the duration of disease in SOD1-associated ALS pedigrees by these properties. However, we find that the majority of pedigrees in which patients exhibit reproducibly short disease durations are associated with mutations that show a high inherent propensity to induce aggregation of SOD1.",
author = "Mercedes Prudencio and Hart, {P. John} and Borchelt, {David R.} and Andersen, {Peter M.}",
year = "2009",
doi = "10.1093/hmg/ddp260",
language = "English (US)",
volume = "18",
pages = "3217--3226",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "17",

}

TY - JOUR

T1 - Variation in aggregation propensities among ALS-associated variants of SOD1

T2 - Correlation to human disease

AU - Prudencio, Mercedes

AU - Hart, P. John

AU - Borchelt, David R.

AU - Andersen, Peter M.

PY - 2009

Y1 - 2009

N2 - To date, 146 different mutations in superoxide dismutase 1 (SOD1) have been identified in patients with familial amyotrophic lateral sclerosis (ALS). The mean age of disease onset in patients inheriting mutations in SOD1 is 45-47 years of age. However, although the length of disease duration is highly variable, there are examples of consistent disease durations associated with specific mutations (e. g. A4V, less than 2 years). In the present study, we have used a large set of data from SOD1-associated ALS pedigrees to identify correlations between disease features and biochemical/biophysical properties of more than 30 different variants of mutant SOD1. Using a reliable cell culture assay, we show that all ALS-associated mutations in SOD1 increase the inherent aggregation propensity of the protein. However, the relative propensity to do so varied considerably among mutants. We were not able to explain the variation in aggregation rates by differences in known protein properties such as enzyme activity, protein thermostability, mutation position or degree of change in protein charge. Similarly, we were not able to explain variability in the duration of disease in SOD1-associated ALS pedigrees by these properties. However, we find that the majority of pedigrees in which patients exhibit reproducibly short disease durations are associated with mutations that show a high inherent propensity to induce aggregation of SOD1.

AB - To date, 146 different mutations in superoxide dismutase 1 (SOD1) have been identified in patients with familial amyotrophic lateral sclerosis (ALS). The mean age of disease onset in patients inheriting mutations in SOD1 is 45-47 years of age. However, although the length of disease duration is highly variable, there are examples of consistent disease durations associated with specific mutations (e. g. A4V, less than 2 years). In the present study, we have used a large set of data from SOD1-associated ALS pedigrees to identify correlations between disease features and biochemical/biophysical properties of more than 30 different variants of mutant SOD1. Using a reliable cell culture assay, we show that all ALS-associated mutations in SOD1 increase the inherent aggregation propensity of the protein. However, the relative propensity to do so varied considerably among mutants. We were not able to explain the variation in aggregation rates by differences in known protein properties such as enzyme activity, protein thermostability, mutation position or degree of change in protein charge. Similarly, we were not able to explain variability in the duration of disease in SOD1-associated ALS pedigrees by these properties. However, we find that the majority of pedigrees in which patients exhibit reproducibly short disease durations are associated with mutations that show a high inherent propensity to induce aggregation of SOD1.

UR - http://www.scopus.com/inward/record.url?scp=68749083546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68749083546&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddp260

DO - 10.1093/hmg/ddp260

M3 - Article

VL - 18

SP - 3217

EP - 3226

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 17

ER -